Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1Sanofi Winthrop Industrie Gentilly FR
02 1SCI PHARMTECH, INC. Taoyuan City TW
03 1ANJAN DRUG PRIVATE LIMITED Alathur IN
04 1ASSURGEN PHARMA PVT LTD Lalamkoduru Village IN
05 1DUPONT NUTRITION BIOSCIENCES APS Brabrand DK
06 1HARMAN FINOCHEM LIMITED Mumbai IN
07 1KATWIJK CHEMIE BV Katwijk ZH NL
08 2SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
09 1The Nippon Synthetic Chemical Industry Co., Ltd. Osaka JP
01 9Valproic acid
02 1Valproic acid, Process II
01 1Denmark
02 1France
03 5India
04 1Japan
05 1Netherlands
06 1Taiwan
01 8Valid
02 2Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : CEP 2004-226 - Rev 05
Status : Valid
Issue Date : 2024-02-02
Type : Chemical
Substance Number : 1378
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
Certificate Number : R1-CEP 2003-108 - Rev 05
Status : Valid
Issue Date : 2019-06-13
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2003-174 - Rev 03
Status : Valid
Issue Date : 2020-02-21
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2020-374 - Rev 01
Status : Valid
Issue Date : 2024-08-26
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2015-158 - Rev 01
Status : Valid
Issue Date : 2024-04-05
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2004-015 - Rev 04
Status : Withdrawn by Holder
Issue Date : 2014-12-04
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 1998-026 - Rev 03
Status : Valid
Issue Date : 2015-08-06
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2006-310 - Rev 04
Status : Valid
Issue Date : 2020-03-11
Type : Chemical
Substance Number : 1378
Certificate Number : CEP 2014-140 - Rev 02
Status : Valid
Issue Date : 2024-04-02
Type : Chemical
Substance Number : 1378
Certificate Number : R1-CEP 2001-287 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2012-10-02
Type : Chemical
Substance Number : 1378
A Valproate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Valproate, including repackagers and relabelers. The FDA regulates Valproate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Valproate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Valproate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Valproate supplier is an individual or a company that provides Valproate active pharmaceutical ingredient (API) or Valproate finished formulations upon request. The Valproate suppliers may include Valproate API manufacturers, exporters, distributors and traders.
click here to find a list of Valproate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Valproate CEP of the European Pharmacopoeia monograph is often referred to as a Valproate Certificate of Suitability (COS). The purpose of a Valproate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Valproate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Valproate to their clients by showing that a Valproate CEP has been issued for it. The manufacturer submits a Valproate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Valproate CEP holder for the record. Additionally, the data presented in the Valproate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Valproate DMF.
A Valproate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Valproate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Valproate suppliers with CEP (COS) on PharmaCompass.
We have 9 companies offering Valproate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
